Instituto De Microcirugia Ocular Dos S.L. — Clinical Trial Site

14 Registered trials

4 Currently recruiting

Organisation

Instituto De Microcirugia Ocular Dos S.L.

Location

Barcelona, Spain

Identifier

ORG-100048592

Address

Calle Del Valle De Pinares Llanos 3, 28035, Spain

Departments

204: Oftalmología
Cornea and Refractive Surgery
Oftalmología
Ophthalmogoly
Ophthalmology
Retina
Servicio de Oftalmologia

Clinical trials at this site (14)

Search interface

Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy Pending

2023-505750-17-00 Neovascular age-related macular degeneration 4
A clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003) Recruiting

2025-524894-17-00 Neovascular age-related macular degeneration (NVAMD) 10 2026-06-22
An efficacy and safety study of cenegermin ophthalmic solution compared with vehicle in the treatment of PCED Recruiting

2025-523443-35-00 Persistent Corneal Epithelial Defect (PCED) 5 2026-06-11
A Phase 3, Multi-Center, Randomized, Parallel, Double Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.1% RG… Recruiting

2024-518969-98-00 Neurotrophic Keratopathy 5 2025-11-04
A multicentric, randomized, double-blind, placebo-controlled trial to evaluate the efficacy of COLIRIOBCN070660 administered topically in pa… Recruiting

2023-505791-30-01 Diabetic Retinopathy 10 2024-04-17
A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF Ended

2025-520809-12-00 Diabetic Macular Edema 10 2025-10-16
A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF (in patients with Diabetic Macular Edema… Ended

2024-510944-30-00 Diabetic Macular Edema 10 2024-11-22
A Randomized, Partially Masked, Controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participan… Ended

2023-503666-23-00 Neovascular age-related macular degeneration 5 2024-06-07
Study to evaluate the long-term safety of GT005 in participants having macular degeneration that led to geographic atrophy in their eyes and… Ended

2024-510946-15-00 Geographic atrophy (GA) secondary to age-related macula 9 2022-12-08
A phase III, randomized, double-masked, placebo-controlled, parallel-group, multicenter study of the safety and efficacy of OT-101 (Atropine… Ended

2024-516315-24-00 myopia 5 2022-05-27
Extension Study to Assess Batoclimab in Participants with TED. Ended

2024-512650-21-00 Thyroid Eye Disease (TED) 5 2023-12-13
Phase 3 Study to Assess Batoclimab in Participants with Active Thyroid Eye Disease Ended

2024-512649-18-00 Thyroid Eye Disease 5 2023-06-05
A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration Ended

2023-508571-37-00 Geographic atrophy (GA) secondary to Age-related Macula 4 2022-04-29
A clinical study of OPT-302 with ranibizumab compared to ranibizumab alone in patients with neovascular age-related macular degeneration Ended

2024-512879-13-00 Neovascular age-related macular degeneration (wet AMD) 5 2021-09-23